Nice one. This confirms why Calimmune called the
first drug 'Cal-1', because they have a 'Cal-2' on its
way, with the latter being the pure play shRNA approach
someone from Calimmune mentioned last year.
So yes H, yet more clinical trials using Blt ip on the way
- Forums
- ASX - By Stock
- BLT
- from the other side
from the other side, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)